-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Initiates Coverage On Korsana Biosciences with Overweight Rating, Announces Price Target of $44

Benzinga·11/13/2026 12:57:18
Listen to the news
Wells Fargo analyst Benjamin Burnett initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Overweight rating and announces Price Target of $44.